Syapse nabs $30 mln Series D
San Francisco-based Syapse, a provider of precision medicine solutions, has raised $30 million in Series D financing. The backers included Ascension Ventures, GE Ventures, Intermountain Healthcare Innovation Fund, Safeguard Scientifics, Social Capital, Amgen Ventures, Medidata Solutions, Merck Global Health Innovation Fund and Roche Venture Fund.
14 November 2017•1 min read
